Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design

Jennifer A. Ligibel; William T. Barry; Catherine Alfano; Dawn L. Hershman; Melinda Irwin; Marian Neuhouser; Cynthia A. Thomson; Linda Delahanty; Elizabeth Frank; Patty Spears; Electra D. Paskett; Judith Hopkins; Vanessa Bernstein; Vered Stearns; Julia White; Olwen Hahn; Clifford Hudis; Eric P. Winer; Thomas A. Wadden; Pamela J. Goodwin

doi:10.1038/s41523-017-0040-8

Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design

npj Breast Cancer ◽

10.1038/s41523-017-0040-8 ◽

2017 ◽

Vol 3 (1) ◽

Cited By ~ 32

Author(s):

Jennifer A. Ligibel ◽

William T. Barry ◽

Catherine Alfano ◽

Dawn L. Hershman ◽

Melinda Irwin ◽

...

Keyword(s):

Breast Cancer ◽

Weight Loss ◽

Early Breast Cancer ◽

Study Design ◽

Adjuvant Treatment ◽

Phase Iii ◽

Obese Women ◽

Phase Iii Trial

Download Full-text

The Breast Cancer Weight Loss (BWEL) trial: Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early-stage breast cancer (Alliance A011401).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.tps598 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. TPS598-TPS598 ◽

Cited By ~ 1

Author(s):

Jennifer A. Ligibel ◽

William Thomas Barry ◽

Catherine M. Alfano ◽

Dawn L. Hershman ◽

Melinda L Irwin ◽

...

Keyword(s):

Breast Cancer ◽

Weight Loss ◽

Adjuvant Treatment ◽

Early Stage ◽

Early Stage Breast Cancer ◽

Phase Iii ◽

Obese Women ◽

Phase Iii Trial

Download Full-text

5-year follow-up of the safety, tolerability and efficacy of subcutaneous trastuzumab for the adjuvant treatment of HER2-positive early breast cancer. Results from the SafeHER Phase III trial

The Breast ◽

10.1016/s0960-9776(21)00097-7 ◽

2021 ◽

Vol 56 ◽

pp. S21-S22

Author(s):

J. Gligorov ◽

X. Pivot ◽

B. Ataseven ◽

M. De Laurentiis ◽

A. Llombart ◽

...

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Adjuvant Treatment ◽

Phase Iii ◽

Her2 Positive ◽

Phase Iii Trial

Download Full-text

Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial

British Journal of Cancer ◽

10.1038/sj.bjc.6603096 ◽

2006 ◽

Vol 94 (9) ◽

pp. 1233-1236 ◽

Cited By ~ 21

Author(s):

C Pacilio ◽

◽

A Morabito ◽

F Nuzzo ◽

A Gravina ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Adjuvant Treatment ◽

Metastatic Breast ◽

Phase Iii ◽

First Line ◽

Single Centre ◽

Phase Iii Trial ◽

Line Chemotherapy

Download Full-text

Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group Study

Breast Cancer Research and Treatment ◽

10.1007/s10549-010-0989-6 ◽

2010 ◽

Vol 122 (3) ◽

pp. 787-794 ◽

Cited By ~ 8

Author(s):

Janine L. Mansi ◽

Ann Yellowlees ◽

Julian Lipscombe ◽

Helena M. Earl ◽

David A. Cameron ◽

...

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Medical Therapy ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study

Download Full-text

Abstract OT-01-02: Adaptlate -a randomized, controlled, open-label, phase-iii trial on adjuvant dynamic marker - adjusted personalized therapy comparing abemaciclib combined with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy in (clinical or genomic) high risk, hr+/her2- early breast cancer

10.1158/1538-7445.sabcs20-ot-01-02 ◽

2021 ◽

Author(s):

Oleg Gluz ◽

Tom Degenhardt ◽

Norbert Marschner ◽

Matthias Christgen ◽

Hans Heinrich Kreipe ◽

...

Keyword(s):

Breast Cancer ◽

High Risk ◽

Endocrine Therapy ◽

Early Breast Cancer ◽

Adjuvant Endocrine Therapy ◽

Phase Iii ◽

Open Label ◽

Phase Iii Trial ◽

Randomized Controlled ◽

Open Label Phase

Download Full-text

5150 CIBOMA/2004–01: a randomised phase III trial assessing adjuvant capecitabine (X) maintenance therapy after standard chemotherapy for triple-negative early breast cancer (EBC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71042-0 ◽

2009 ◽

Vol 7 (2) ◽

pp. 305 ◽

Cited By ~ 3

Author(s):

A. Lluch ◽

L. Torrecillas ◽

C.H. Barrios ◽

J. Bines ◽

H. Gómez ◽

...

Keyword(s):

Breast Cancer ◽

Maintenance Therapy ◽

Early Breast Cancer ◽

Triple Negative ◽

Phase Iii ◽

Standard Chemotherapy ◽

Phase Iii Trial

Download Full-text

A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results

European Journal of Cancer ◽

10.1016/j.ejca.2018.01.072 ◽

2018 ◽

Vol 93 ◽

pp. 19-27 ◽

Cited By ~ 29

Author(s):

X. Pivot ◽

I. Bondarenko ◽

Z. Nowecki ◽

M. Dvorkin ◽

E. Trishkina ◽

...

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Adjuvant Treatment ◽

Reference Product ◽

Phase Iii ◽

Her2 Positive ◽

Phase Iii Study

Download Full-text

Abstract S4-1: FinXX Final 5-Year Analysis: Results of the Randomised, Open-Label, Phase III Trial in Medium-to-High Risk Early Breast Cancer

10.1158/0008-5472.sabcs10-s4-1 ◽

2010 ◽

Cited By ~ 5

Author(s):

H Joensuu ◽

P-L Kellokumpu-Lehtinen ◽

R Huovinen ◽

A Jukkola-Vuorinen ◽

M Tanner ◽

...

Keyword(s):

Breast Cancer ◽

High Risk ◽

Early Breast Cancer ◽

Phase Iii ◽

Open Label ◽

Phase Iii Trial ◽

Open Label Phase

Download Full-text

Abstract OT3-1-06: CIBOMA/2004-01_GEICAM/2003-11: A randomised phase III trial assessing adjuvant capecitabine (Cap) maintenance therapy after standard chemotherapy for triple-negative early breast cancer (EBC)

10.1158/0008-5472.sabcs13-ot3-1-06 ◽

2013 ◽

Cited By ~ 1

Author(s):

CE Barrios ◽

A Lluch ◽

M Ruiz-Borrego ◽

J Bines ◽

L Torrecillas ◽

...

Keyword(s):

Breast Cancer ◽

Maintenance Therapy ◽

Early Breast Cancer ◽

Triple Negative ◽

Phase Iii ◽

Standard Chemotherapy ◽

Phase Iii Trial

Download Full-text

Aster 70S Unicancer Phase III Trial : Adjuvant Treatment for Women Over 70 with Luminal Breast Cancer

Annals of Oncology ◽

10.1093/annonc/mdu327.75 ◽

2014 ◽

Vol 25 ◽

pp. iv108

Author(s):

C. Dubot ◽

Y. Tazi ◽

E. Bourbouloux ◽

S. Kirscher ◽

O. Rigal ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Treatment ◽

Phase Iii ◽

Luminal Breast Cancer ◽

Phase Iii Trial

Download Full-text